How are NFTs formed in
the brain?
NFTs are insoluble tangles of soluble phosphoproteins
called tau. Because these tangles start
forming inside neurons they are called neurofibrillary tangles or NFTs. The appearance in the brain of these NFTs as “tombstones” or
“ghosts” is one of the hallmarks of AD. NFT formation requires two things:
·
An above normal amount of phosphoryl groups (PO32-)
coated on the tau proteins. This phosphoryl coated tau protein is called hyper-phosphorylated
tau.
·
Metal ions that facilitate the formation and pairing of hyper-phosphorylated
tau to form paired helical filaments (PHFt) called NFTs.
Lesions in
the brain caused by NFTs are better correlated with cognitive decline in AD
than intracellular Aβ oligomer and extracellular Aβ plaque formation19.
Does aluminum
cause NFTs or does aluminum complex with NFTs after they form?
Some metal cations inhibit
numerous key enzymes in the brain. One
of these key enzymes is PP2A that keeps tau from being covered with too many phosphoryl
(PO32-) groups (i.e. over-phosphorylated). When PP2A is inhibited by zinc20,
mercury21, or aluminum22 ions the result is
over-phosphorylation of tau leading to PHFt formation, neuronal death, and ultimately neurofibrillary tangles in
place of former neurons. Of the three cations that
are known to inhibit PP2A, zinc is a neurotransmitter that is required by our
brains and zinc and mercury are not on the list of suspects in the case of
strange death as they are not contained in alum. Therefore Watson, zinc and
mercury are “red-herrings” and this leaves aluminum in alum on the suspect
list.
In 1988 aluminum chloride added to rat brain cells
resulted in NFTs that were “distinct” immunochemically from human Alzheimer NFTs23. This resulted in more controversy but was
resolved in 1998 when aluminum chloride was injected into the cerebrospinal
fluid in the brains of New Zealand white rabbits24. The resulting NFTs were immunochemically
identical to NFTs found in the brains of AD patients. In 1992 it was found that
aluminum stimulates the interaction between filaments of hyper-phosphorylated
tau. This interaction results in paired helical filaments of tau (PHFt) and NFT formation25.
Is
aluminum linked to NFTs in neurons?
In 1973 levels of aluminum were found to be higher
than normal in some regions of the brains of Alzheimer patients26.
This finding remained controversial until 1980 when a combination scanning
electron microscope and x-ray spectrometer analysis showed there was aluminum
in neurons with NFTs in the brains of both Alzheimer and elderly non-Alzheimer
patients and no aluminum in adjacent neurons without NFTs27. Since NFTs are a hallmark of AD, this finding
was the first to link aluminum to AD at the neuronal level. Even more disturbing was the fact that
aluminum and NFTs are in the neurons of the elderly in general not just those
with an AD diagnosis. These findings are
consistent with research that finds aluminum in the brains of the elderly in
general28,29.
Aluminum is a non-essential cation in our brains
and an unwanted intruder. It is obvious
Watson, since aluminum promotes the formation of paired helical filaments of
tau and NFTs, NFTs are at best only a secondary cause or symptom and not the
primary cause of Alzheimer’s.
But Watson was looking
skeptical and asked: “Since aluminum is looking more and more like the culprit
in the case of strange death, why do people with the apoE4 gene have a 50%
higher chance of getting AD than people without this gene?”
Holmes replied: Carriers of the apoE4 gene have lived with higher levels
of Aβ peptides, oligomers, and plaque for
thousands of years and not had AD. There
must be an environmental factor that facilitates the formation of Aβ peptides,
oligomers, or plaque to cause AD”.
Watson asked: “Could this
environmental factor be aluminum?”
Yes Watson
aluminum is a likely environmental casual factor of AD. Metal cations such as
aluminum, copper, zinc, and iron are known to complex with Aβ peptides to form Aβ oligomers16,17. However, only aluminum complexes of Aβ oligomers are neurotoxic16. Aluminum makes the degree of neurotoxicity
worse because it has the unique property of “freezing” Aβ peptides in the oligomeric state, resulting in high concentrations of Aβ oligomers16. When
these Aβ oligomers are complexed with aluminum they cause excess calcium to
diffuse into neurons which can ultimately kill them. Therefore aluminum can cause AD both with and
without the apoE4 gene but is 50% more likely to cause AD in carriers of the
apoE4 gene. This is due to the carriers having higher levels of Aβ peptides in their brains making it possible for aluminum to freeze more
Aβ peptides in the neurotoxic oligomeric state.
Aluminum acts in five ways to increase the
accumulation of Aβ oligomers in the brain putting carriers of the apoE4 gene at greater risk of
getting AD:
·
Aluminum freezes Aβ peptides in the neurotoxic
oligomeric state16.
·
Aluminum lowers gene expression of neprilysin,
an enzyme that is the rate limiting step in Aβ peptide and oligomer degradation30,31.
·
Aluminum lowers gene
expression of the LDL receptor LRP1, required for Aβ peptide clearance and the
importation of cholesterol to neurons30,32.
·
Aluminum increases gene
expression of BACE1, the β-secretase enzyme that cleaves the amyloid
precursor protein (APP) to the precursor of Aβ peptides30,31.
·
Aluminum increases gene
expression for the production of APP, the precursor of Aβ peptides31.
Those with
the apoE4 gene are also more likely to get AD due to head trauma or aluminum
accumulation leading to an ischemic event, such as stroke. Ischemia occurs when blood flow is
temporarily suspended to some regions of the brain. Sporadic AD is believed to
be associated in some cases with an ischemic event33. Post mortem analysis of the brains of those
with AD has shown that 30% have evidence of an ischemic event33. Shortly after an ischemic event there is increased
genetic expression of an apoE protein, such as apoE433. Also there is both an increased genetic
expression of amyloid precursor protein (APP) and the enzyme β-secretase (BACE1) that cleaves APP to the precursor of Aβ peptides33. Those
with the apoE4 gene have slower Aβ
peptide clearance than normal. Because
of this, after an ischemic event there is even less clearance than normal in the
brains of those with the apoE4 gene and more production of Aβ peptides and Aβ oligomers.
Accumulation of aluminum in the brain increases
the toxicity of Aβ oligomers, the amount of aluminum-complexed Aβ oligomers, and
the likelihood of an ischemic event (see Chapter 2). Aluminum
is a likely environmental causal factor for both toxic Aβ oligomers and ischemic events and puts people with the apoE4 gene at greater risk than
normal for AD.
Watson, this is the second crux of the case. Since Aβ oligomers are only a facilitating factor for AD they can be
removed from our list of suspects.
Watson looked alarmed for the
first time and asked: “Is there aluminum
in my brain that is ‘freezing’ neurotoxic Aβ peptides in the oligomeric state?” Holmes replied “I am afraid
that we are all suffering from some frozen neurotoxic Aβ oligomers. But luckily
we can control the amount of aluminum we ingest, absorb, and excrete. As you have
sensed Watson, the sum total of this research has now reached a tipping point”.
Aluminum is the only
remaining suspect for causing the case of strange death. But before we can be certain that aluminum is
the culprit we need to find if aluminum has the means and motive to cause AD in
the case of strange death.